| Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy (NCT00629187) | Tufts Medical Center | 2004-04-01 |
| Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) (NCT00076856) | Merck Sharp & Dohme LLC | 2004-03-31 |
| Docetaxel and Capecitabine in Advanced Gastric Cancer (NCT00142038) | Charite University, Berlin, Germany | 2004-03-01 |
| Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer (NCT00133913) | Immunicon | 2004-03-01 |
| A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer (NCT00459654) | Bayer | 2004-02-01 |
| Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors (NCT00075166) | National Institute of Neurological Disorders and Stroke (NINDS) | 2003-12-01 |
| Dexamethasone for Palliation - Brain Metastases (NCT00188864) | University Health Network, Toronto | 2003-11-01 |
| Tarceva and Capecitabine for Pancreatic Cancer (NCT00125021) | Dana-Farber Cancer Institute | 2003-10-01 |
| Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases (NCT00068068) | Light Sciences LLC | 2003-10-01 |
| Analyses of Human Samples Collected in Clinical Trials (NCT00339664) | National Cancer Institute (NCI) | 2003-07-02 |
| Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer (NCT00072865) | Eli Lilly and Company | 2003-06-01 |
| ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00101920) | Amgen | 2003-06-01 |
| Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy (NCT00067314) | Pfizer | 2003-06-01 |
| PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) (NCT00221702) | University Hospital, Bordeaux | 2003-06-01 |
| A Research Study for Patients With Metastatic Renal Cell Carcinoma (NCT00106613) | Celgene | 2003-05-01 |
| Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer (NCT00123851) | Dana-Farber Cancer Institute | 2003-03-01 |
| Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma (NCT00055562) | Celgene Corporation | 2003-01-01 |
| A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases (NCT00124761) | Royal Adelaide Hospital | 2002-12-01 |
| A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis (NCT00149201) | Japan Clinical Oncology Group | 2002-11-01 |
| Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma. (NCT00057616) | Celgene | 2002-10-01 |
| Study of NS-9 in Patients With Liver Metastases (NCT00094003) | NS Pharma, Inc. | 2002-09-01 |
| Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions (NCT00130494) | Spanish Breast Cancer Research Group | 2002-08-29 |
| Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions (NCT00171964) | Novartis Pharmaceuticals | 2002-05-01 |
| Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer (NCT00171587) | Novartis | 2002-05-01 |
| For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy (NCT00037180) | Pfizer | 2002-04-01 |
| Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases (NCT00119899) | Radboud University Medical Center | 2002-03-01 |
| A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer (NCT00122291) | Alberta Health services | 2002-01-01 |
| ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00034346) | Amgen | 2002-01-01 |
| PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy (NCT01696565) | PhytoHealth Corporation | 2001-12-01 |
| Study of Noni in Cancer Patients (NCT00033878) | National Center for Complementary and Integrative Health (NCCIH) | 2001-11-01 |
| ADI-PEG in Patients With Metastatic Melanoma (NCT00029900) | FDA Office of Orphan Products Development | 2001-09-01 |
| Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases (NCT01798108) | Bayer | 2001-08-14 |
| Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases (NCT00129051) | Alberta Health services | 2001-08-01 |
| Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host (NCT00149032) | Hadassah Medical Organization | 2001-08-01 |
| Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia (NCT00127387) | The University of Texas Health Science Center at San Antonio | 2001-05-01 |
| Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas (NCT00023166) | Enzon Pharmaceuticals, Inc. | 2001-05-01 |
| Molecular Markers in Treatment in Endometrial Cancer (NCT00598845) | University of Bergen | 2001-04-01 |
| Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients (NCT00128310) | Spanish Breast Cancer Research Group | 2001-01-18 |
| Pamidronate Administration in Breast Cancer Patients With Bone Metastases (NCT00128297) | Spanish Breast Cancer Research Group | 2000-10-18 |
| Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria (NCT00004988) | National Cancer Institute (NCI) | 2000-03-01 |
| Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) (NCT00289445) | University Hospital Tuebingen | 1999-09-01 |
| Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma (NCT00001832) | National Cancer Institute (NCI) | 1999-08-01 |
| Stem Cell Transplantation for Metastatic Solid Tumors (NCT00001880) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-03-12 |
| A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer (NCT00190489) | Japan Clinical Oncology Group | 1999-01-01 |
| Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence (NCT00001705) | National Cancer Institute (NCI) | 1998-07-01 |
| Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase (NCT00001685) | National Cancer Institute (NCI) | 1997-11-01 |
| A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver (NCT00001587) | National Cancer Institute (NCI) | 1997-09-01 |
| A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer (NCT00001570) | National Cancer Institute (NCI) | 1997-02-01 |
| Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer (NCT00001507) | National Cancer Institute (NCI) | 1996-07-12 |
| Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases (NCT00138788) | St George Hospital, Australia | 1996-02-01 |
| Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer (NCT00001493) | National Cancer Institute (NCI) | 1995-10-01 |
| Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy (NCT00001440) | National Cancer Institute (NCI) | 1995-07-01 |
| A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma (NCT00001436) | National Cancer Institute (NCI) | 1995-05-01 |
| Direct Injection of Alcohol for the Treatment of Spinal Tumors (NCT00001417) | National Institute of Neurological Disorders and Stroke (NINDS) | 1994-06-01 |
| A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 (NCT00001302) | National Cancer Institute (NCI) | 1992-09-01 |
| Gene Therapy for the Treatment of Brain Tumors (NCT00001328) | National Institute of Neurological Disorders and Stroke (NINDS) | 1992-08-21 |
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma (NCT00001270) | National Cancer Institute (NCI) | 1991-06-01 |
| Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer (NCT00001269) | National Cancer Institute (NCI) | 1991-05-01 |
| A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer (NCT00001193) | National Cancer Institute (NCI) | 1984-11-01 |
| Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas (NCT00001165) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1978-09-01 |
| Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation (NCT00178243) | University of Rochester | |
| Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas (NCT00116389) | Point Therapeutics | |
| Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases (NCT00121420) | Pharmacyclics LLC. | |
| Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors (NCT07675057) | Eli Lilly and Company | |
| Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer (NCT00701168) | Leo W. Jenkins Cancer Center | |